CBIO
Crescent Biopharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$11.18
-0.38 ▼ -3.29%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$11.18
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -15.35 | Insider Own | 28.91% | Shs Outstand | 0.03B | Perf Week | -7.37% |
| Market Cap | 0.31B | Forward P/E | - | EPS next Y | 4.31% | Insider Trans | 20.58% | Shs Float | 0.02B | Perf Month | 18.31% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | -0.88 | Inst Own | 72.37% | Short Float | 7.38% | Perf Quarter | -22.84% |
| Income | -0.14B | P/S | 28.42 | EPS this Y | 71.72% | Inst Trans | 44.95% | Short Ratio | 8.55 | Perf Half Y | -10.92% |
| Sales | 0.01B | P/B | 1.55 | EPS next 5Y | 31.7% | ROA | -112.29% | Short Interest | 1.45M | Perf YTD | -5.73% |
| Book/sh | 7.22 | P/C | 1.45 | EPS past 3/5Y | 45.01% 33.26% | ROE | -135.5% | 52W High | -61.14% ($28.77) | Perf Year | -56.93% |
| Cash/sh | 7.74 | P/FCF | - | Sales past 3/5Y | 424.86% 1.31% | ROIC | -69.11% | 52W Low | 28.21% ($8.72) | Perf 3Y | -92.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 73.87% | Gross Margin | 99.23% | Volatility(W/M) | 9.32% 9.12% | Perf 5Y | -96.62% |
| Dividend TTM | - | EV/Sales | 9.27 | Sales Y/Y TTM | -100% | Oper. Margin | -1298.47% | ATR (14) | 0.99 | Perf 10Y | -98.03% |
| Dividend Ex-Date | - | Quick Ratio | 6.56 | EPS Q/Q | 59.1% | Profit Margin | -1301.53% | RSI (14) | 47.83 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.56 | Sales Q/Q | - | SMA20 | -2.31% ($11.44) | Beta | 1.34 | Target Price | $28.33 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2000000 | SMA50 | -0.28% ($11.21) | Rel Volume | 0.66 | Prev Close | $11.56 |
| Employees | 44 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -62.25% 8.44% | SMA200 | -14.6% ($13.09) | Avg Volume(3M) | 0.17M | Price | $11.18 |
| IPO | 2014/1/10 | Option/Short | No/Yes | Trades | 2133 | Volume | 112,276 | Change | -3.29% |
뉴스 로딩 중...